Page last updated: 2024-09-03

7-methyl-6,8-bis(methylthio)pyrrolo(1,2-a)pyrazine and Liver Cirrhosis

7-methyl-6,8-bis(methylthio)pyrrolo(1,2-a)pyrazine has been researched along with Liver Cirrhosis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cho, SH; Choi, JY; Choi, YH; Chon, CY; Han, JY; Jang, JJ; Jang, JW; Kim, SG; Kim, YM; Lee, DH; Lee, MG; Lee, YS; Um, SH; Yu, ES1

Trials

1 trial(s) available for 7-methyl-6,8-bis(methylthio)pyrrolo(1,2-a)pyrazine and Liver Cirrhosis

ArticleYear
Pharmacokinetics of oltipraz and its major metabolite (RM) in patients with liver fibrosis or cirrhosis: relationship with suppression of circulating TGF-beta1.
    Clinical pharmacology and therapeutics, 2010, Volume: 88, Issue:3

    Topics: Administration, Oral; Adult; Antiviral Agents; Area Under Curve; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Half-Life; Humans; Liver Cirrhosis; Male; Middle Aged; Pyrazines; Thiones; Thiophenes; Transforming Growth Factor beta1

2010